Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immunovant, Inc. | 270,252 | reported | 20 May 2026 | tx 24+418,142−32,100 |
| Axovant Sciences Ltd. | 42,000 | reported | 15 Apr 2021 | tx 10+496,870 |
| Karuna Therapeutics, Inc. | 0 | reported | 18 Mar 2024 | tx 74+134,608−175,322 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | EXERCISE | Immunovant, Inc. | 6,000 | 8.43 USD | 10b5-1 |
| 20 May 2026 | SALE | Immunovant, Inc. | 6,000 | 32.00 USD | 10b5-1 |
| 20 May 2026 | EXERCISE | Immunovant, Inc. | 6,000 | 0.00 USD | 10b5-1deriv |
| 01 Apr 2025 | GRANT_AWARD | Immunovant, Inc. | 16,188 | 0.00 USD | |
| 01 Apr 2025 | GRANT_AWARD | Immunovant, Inc. | 7,600 | 0.00 USD | deriv |
| 02 Dec 2024 | SALE | Immunovant, Inc. | 7,750 | 28.54 USD | |
| 02 Apr 2024 | GRANT_AWARD | Immunovant, Inc. | 11,255 | 0.00 USD | |
| 02 Apr 2024 | GRANT_AWARD | Immunovant, Inc. | 4,690 | 0.00 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 990 | 330.00 USD | |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 1,904 | 92.30 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 5,000 | 227.04 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 8,500 | 201.99 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 12,500 | 232.41 USD | deriv |
| 01 Dec 2023 | SALE | Immunovant, Inc. | 4,129 | 38.80 USD | |
| 01 Dec 2023 | SALE | Immunovant, Inc. | 3,374 | 39.82 USD | |
| 01 Dec 2023 | SALE | Immunovant, Inc. | 4,847 | 40.46 USD | |
| 20 Jun 2023 | GRANT_AWARD | Karuna Therapeutics, Inc. | 990 | 0.00 USD | |
| 20 Jun 2023 | GRANT_AWARD | Karuna Therapeutics, Inc. | 1,904 | 0.00 USD | deriv |
| 12 Apr 2023 | GRANT_AWARD | Immunovant, Inc. | 12,523 | 0.00 USD | |
| 12 Apr 2023 | GRANT_AWARD | Immunovant, Inc. | 16,260 | 0.00 USD | deriv |
| 30 Sept 2022 | PURCHASE | Immunovant, Inc. | 15,000 | 5.60 USD | first after silence |
| 17 Aug 2022 | GRANT_AWARD | Immunovant, Inc. | 21,059 | 0.00 USD | |
| 17 Aug 2022 | GRANT_AWARD | Immunovant, Inc. | 31,668 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Karuna Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 01 Feb 2022 | EXERCISE | Karuna Therapeutics, Inc. | 2,500 | 16.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 30 Sept 2022.